Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating multiple intra-articular injections of LRX712 in knee osteoarthritis reports safety, tolerability and preliminary efficacy, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• LRX712

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoarthritis (OA) | Phase 2 | Status: COMPLETED | Results posted: 2026-01-07